1. Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial. Issue 10358 (1st October 2022) Authors: Pal, Sumanta Kumar; Uzzo, Robert; Karam, Jose Antonio; Master, Viraj A; Donskov, Frede; Suarez, Cristina; Albiges, Laurence; Rini, Brian; Tomita, Yoshihiko; Kann, Ariel Galapo; Procopio, Giuseppe; Massari, Francesco; Zibelman, Matthew; Antonyan, Igor; Huseni, Mahrukh; Basu, Debasmita; Ci, Bo; Leu... Journal: Lancet Issue: Volume 400:Issue 10358(2022) Page Start: 1103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant chemotherapy for older adults with breast cancer: making the standard a standard. (September 2009) Authors: Pal, Sumanta Kumar; Mortimer, Joanne Journal: Women's health Issue: Volume 5:Number 5(2009) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association between chemotherapy toxicity risk scores and physical symptoms among older Brazilian adults with cancer. Issue 2 (March 2020) Authors: Bergerot, Cristiane Decat; Razavi, Marianne; Philip, Errol J.; Bergerot, Paulo Gustavo; Soto-Perez-de-Celis, Enrique; De Domenico, Edvane Birelo Lopes; Clark, Karen Lynn; Loscalzo, Matthew; Pal, Sumanta Kumar; Dale, William Journal: Journal of geriatric oncology Issue: Volume 11:Issue 2(2020) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Biopsychosocial distress and clinical outcome in metastatic renal cell carcinoma. Issue 3 (18th June 2018) Authors: Bergerot, Cristiane Decat; Clark, Karen Lynn; Ashing, Kimlin Tam; Bergerot, Paulo Gustavo; Obenchain, Richard; Dizman, Nazli; Hsu, JoAnn; Philip, Errol; Loscalzo, Matthew; Pal, Sumanta Kumar Journal: Palliative & supportive care Issue: Volume 17:Issue 3(2019) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cytoreductive nephrectomy for favorable risk patients with metastatic renal cell carcinoma? Yes, cytoreductive nephrectomy should still be considered. Issue 5 (September 2020) Authors: Meza, Luis; Chehrazi-Raffle, Alexander; Pal, Sumanta Kumar Journal: Current opinion in urology Issue: Volume 30:Issue 5(2020:Sep.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status. Issue 3 (2nd October 2020) Authors: Bergerot, Cristiane Decat; Philip, Errol J.; Bergerot, Paulo Gustavo; Hsu, JoAnn; Dizman, Nazli; Salgia, Megan; Salgia, Nicholas; Vaishampayan, Ulka; Battle, Dena; Loscalzo, Matthew; Dale, William; Pal, Sumanta Kumar Journal: Cancer Issue: Volume 127:Issue 3(2021) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Distress in patients with renal cell carcinoma: a curious gap in knowledge. (24th October 2018) Authors: Bergerot, Cristiane Decat; Battle, Dena; Staehler, Michael D.; Pal, Sumanta Kumar Journal: BJU international Issue: Volume 123:Number 2(2019) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Emotional problem‐related distress screening and its prevalence by cancer type: Assessment by patients' characteristics and level of assistance requested. Issue 8 (13th April 2021) Authors: Bergerot, Cristiane Decat; Razavi, Marianne; Clark, Karen Lynn; Philip, Errol J; Pal, Sumanta Kumar; Loscalzo, Matthew; Dale, William Journal: Psycho-oncology Issue: Volume 30:Issue 8(2021) Page Start: 1332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Geography: an increasingly important variable in prostate cancer clinical trials. (January 2015) Authors: Sartor, Oliver; Pal, Sumanta Kumar; Hermanson, Terhi; Bennett, Charles L. Journal: BJU international Issue: Volume 115:Number 1(2015:Jan.) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC). Issue 6 (19th December 2017) Authors: Pal, Sumanta Kumar; Patel, Jaymala; He, Miaoling; Foulk, Brad; Kraft, Katherine; Smirnov, Denis A.; Twardowski, Przemyslaw; Kortylewski, Marcin; Bhargava, Vipul; Jones, Jeremy O. Journal: Cancer Issue: Volume 124:Issue 6(2018) Page Start: 1216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗